Benzinga | Jan 20, 2022 09:43AM EST

Sidoti & Co. Upgrades PetMed Express to Buy, Announces $32 Price Target

Sidoti & Co. analyst Anthony Lebiedzinski upgrades PetMed Express (NASDAQ:PETS) from Neutral to Buy and announces $32 price target.